Product Code: ETC8987363 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Russia Basal Insulin (Long Acting Insulin) Market Overview |
3.1 Russia Country Macro Economic Indicators |
3.2 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, 2021 & 2031F |
3.3 Russia Basal Insulin (Long Acting Insulin) Market - Industry Life Cycle |
3.4 Russia Basal Insulin (Long Acting Insulin) Market - Porter's Five Forces |
3.5 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume Share, By Products, 2021 & 2031F |
4 Russia Basal Insulin (Long Acting Insulin) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Russia |
4.2.2 Growing awareness about the benefits of long-acting insulin therapy |
4.2.3 Technological advancements in insulin delivery devices |
4.2.4 Government initiatives to improve diabetes management in the country |
4.3 Market Restraints |
4.3.1 High cost associated with long-acting insulin products |
4.3.2 Limited access to healthcare services in remote regions of Russia |
4.3.3 Regulatory challenges in the approval process for new insulin products |
5 Russia Basal Insulin (Long Acting Insulin) Market Trends |
6 Russia Basal Insulin (Long Acting Insulin) Market, By Types |
6.1 Russia Basal Insulin (Long Acting Insulin) Market, By Products |
6.1.1 Overview and Analysis |
6.1.2 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Products, 2021- 2031F |
6.1.3 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Lantus, 2021- 2031F |
6.1.4 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Levemir, 2021- 2031F |
6.1.5 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Tresiba, 2021- 2031F |
6.1.6 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Toujeo, 2021- 2031F |
6.1.7 Russia Basal Insulin (Long Acting Insulin) Market Revenues & Volume, By Basaglar, 2021- 2031F |
7 Russia Basal Insulin (Long Acting Insulin) Market Import-Export Trade Statistics |
7.1 Russia Basal Insulin (Long Acting Insulin) Market Export to Major Countries |
7.2 Russia Basal Insulin (Long Acting Insulin) Market Imports from Major Countries |
8 Russia Basal Insulin (Long Acting Insulin) Market Key Performance Indicators |
8.1 Average time taken for regulatory approval of new long-acting insulin products in Russia |
8.2 Patient adherence rate to prescribed long-acting insulin therapy |
8.3 Number of healthcare facilities offering diabetes management programs in Russia |
8.4 Percentage increase in the adoption of long-acting insulin therapy in Russia |
8.5 Average waiting time for patients to access long-acting insulin products in major cities |
9 Russia Basal Insulin (Long Acting Insulin) Market - Opportunity Assessment |
9.1 Russia Basal Insulin (Long Acting Insulin) Market Opportunity Assessment, By Products, 2021 & 2031F |
10 Russia Basal Insulin (Long Acting Insulin) Market - Competitive Landscape |
10.1 Russia Basal Insulin (Long Acting Insulin) Market Revenue Share, By Companies, 2024 |
10.2 Russia Basal Insulin (Long Acting Insulin) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |